Nurix Therapeutics Ratios (2019-2025) | NRIX

Ratios Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Feb2021 May2021 Aug2021 Nov2021 Feb2022 May2022 Aug2022 Nov2022 Feb2023 May2023 Aug2023 Nov2023 Feb2024 May2024 Aug2024 Nov2024 Feb2025 May2025 Aug2025
Profitability
EBT Margin -22.84%-714.77%-432.26%-311.02%-453.29%-297.10%-483.02%-370.09%-282.46%-509.17%-442.09%-397.14%-423.58%-688.74%-321.11%-79.14%-200.26%-276.77%-249.79%-367.65%-388.26%-440.69%-305.38%-96.93%-1,094.77%
EBIT Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%
EBITDA Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%
Operating Margin -24.69%-728.46%-438.30%-316.36%-469.82%-299.12%-489.36%-372.50%-282.84%-513.16%-444.28%-399.89%-432.93%-717.82%-338.60%-87.25%-216.67%-299.06%-272.65%-401.42%-433.83%-486.73%-340.67%-109.68%-1,157.65%
Net Margin -22.94%-726.05%-432.65%181.25%-453.29%-297.44%-484.43%-372.05%-281.26%-509.59%-442.09%-397.14%-423.58%-688.74%-321.11%-79.14%-200.26%-276.77%-250.33%-368.39%-388.91%-440.75%-305.38%-98.66%-1,094.77%
FCF Margin -735.82%1,417.88%-383.60%-191.21%-319.75%143.88%-474.21%-310.54%-429.60%-479.18%-312.31%-460.81%-597.38%-399.91%-63.73%-236.05%159.01%-270.33%-344.38%-353.70%-382.84%-349.93%-149.44%-761.29%
Efficiency
Assets Average 404.11M396.50M457.32M505.53M484.92M457.25M416.01M426.82M438.05M393.46M360.39M329.41M331.90M334.14M411.85M512.32M591.47M642.19M603.30M557.01M
Equity Average -51.08M298.94M280.20M334.16M386.70M358.76M324.11M286.33M304.64M323.12M288.87M266.99M246.87M217.16M184.62M269.72M373.77M451.92M503.95M464.26M409.93M
Invested Capital -44.44M-57.71M307.62M290.27M270.13M398.18M375.22M342.30M305.92M266.74M342.55M303.70M274.05M259.92M233.82M200.49M168.75M370.69M376.86M526.99M480.92M447.60M372.25M
Asset Utilization Ratio 0.040.050.050.060.060.080.090.090.090.110.170.210.230.240.150.110.090.090.150.15
Leverage & Solvency
Equity Ratio -1.310.750.730.680.770.760.720.700.680.750.730.740.740.760.560.540.730.730.790.780.760.71
Valuation
Enterprise Value -51.85M-37.72M603.54M1,374.87M1,082.41M851.27M1,086.20M990.02M461.43M156.27M395.49M221.74M168.64M198.97M150.85M13.79M359.85M975.85M1,175.13M956.61M622.77M324.60M285.21M
Market Capitalization 957.79M1,656.02M1,385.49M1,237.29M1,430.10M1,285.74M723.41M453.55M739.97M530.88M445.79M480.15M409.70M301.69M603.84M1,418.99M1,623.18M1,566.19M1,172.45M810.38M714.04M
Return Ratios
Return on Sales -1.07%-2.84%-2.43%-2.76%-3.89%-3.42%-3.94%-3.94%-3.99%-4.37%-4.67%-4.28%-2.58%-2.17%-1.87%-1.79%-2.65%-3.14%-3.55%-3.69%-2.35%-2.93%
Return on Capital Employed -0.18%-0.22%-0.22%-0.22%-0.28%-0.35%-0.45%-0.48%-0.50%-0.56%-0.57%-0.59%-0.63%-0.64%-0.54%-0.45%-0.43%-0.42%-0.44%-0.56%
Return on Invested Capital -0.15%-0.20%-0.21%
Return on Assets -0.11%-0.14%-0.19%-0.20%-0.24%-0.30%-0.37%-0.40%-0.41%-0.45%-0.44%-0.45%-0.43%-0.43%-0.40%-0.35%-0.33%-0.32%-0.34%-0.44%
Return on Equity -0.14%-0.20%-0.27%-0.26%-0.33%-0.42%-0.54%-0.56%-0.56%-0.62%-0.59%-0.60%-0.66%-0.78%-0.61%-0.47%-0.43%-0.41%-0.45%-0.60%